Assessment and management of cerebral edema and intracranial hypertension in acute liver failure

Journal of Critical Care

Volumn 28, Issue 5, 2013, Pages 783-791

  Mohsenin, Vahid ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute liver failure; Brain edema; Hepatic encephalopathy

Indexed keywords

INDOMETACIN; LACTULOSE; MANNITOL; PARACETAMOL; PENTOBARBITAL; PHENYTOIN; PROPOFOL; RIFAXIMIN; SODIUM CHLORIDE;

ACUTE LIVER FAILURE; ALBUMIN DIALYSIS; BRAIN EDEMA; BRAIN HERNIA; COMA; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS HEMOFILTRATION; DEHYDRATION; DRUG CLEARANCE; DRUG EFFECT; HEPATIC ENCEPHALOPATHY; HUMAN; HYPONATREMIA; INDUCED HYPOTHERMIA; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE MONITORING; LIVER TRANSPLANTATION; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIMETRY; PATHOGENESIS; POINT OF CARE TESTING; REVIEW; SEDATION; SEIZURE; SEPSIS; THERAPEUTIC HYPERVENTILATION; TOXIC HEPATITIS; TRANSCRANIAL DOPPLER;

ACUTE LIVER FAILURE; BRAIN EDEMA; HEPATIC ENCEPHALOPATHY;

BRAIN EDEMA; HUMANS; INTRACRANIAL HYPERTENSION; LIVER FAILURE, ACUTE; MONITORING, PHYSIOLOGIC;

EID: 84883560558     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.04.002     Document Type: Review

References (56)

1. O'Grady J.G., Schalm S.W., Williams R. Acute liver failure: redefining the syndromes. Lancet 1993, 342:273-275.
2. Khashab M., Tector A.J., Kwo P.Y. Epidemiology of acute liver failure. Curr Gastroenterol Rep 2007, 9:66-73.
3. Larson A.M., Polson J., Fontana R.J., et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005, 42:1364-1372.
4. Bernal W., Auzinger G., Dhawan A., et al. Acute liver failure. Lancet 2010, 376:190-201.
5. Conn H.O., Leevy C.M., Vlahcevic Z.R., et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977, 72:573-583.
6. Cordoba J., Blei A.T. Brain edema and hepatic encephalopathy. Semin Liver Dis 1996, 16:271-280.
7. Detry O., De Roover A., Honore P., et al. Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management. World J Gastroenterol 2006, 12:7405-7412.
8. Blei A.T. Brain edema in acute liver failure. Crit Care Clin 2008, 24:99-114.
9. Wendon J., Lee W. Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. Neurocrit Care 2008, 9:97-102.
10. Bernal W., Hall C., Karvellas C.J., et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007, 46:1844-1852.
11. Riordan S.M., Williams R. Perspectives on liver failure: past and future. Semin Liver Dis 2008, 28:137-141.
12. Ostapowicz G., Fontana R.J., Schiodt F.V., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137:947-954.
13. Bemeur C., Butterworth R.F. Liver-brain proinflammatory signalling in acute liver failure: role in the pathogenesis of hepatic encephalopathy and brain edema. Metab Brain Dis 2012, Dec 5. [Epub ahead of print].
14. Wright G., Shawcross D., Olde Damink S.W., et al. Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab Brain Dis 2007, 22:375-388.
15. Kato M., Hughes R.D., Keays R.T., et al. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 1992, 15:1060-1066.
16. Amodio P., Montagnese S., Gatta A., et al. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004, 19:253-267.
17. Dahaba A.A., Worm H.C., Zhu S.M., et al. Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy: a multicentre, observer blinded, validation study. Gut 2008, 57:77-83.
18. Munoz S.J. Difficult management problems in fulminant hepatic failure. Semin Liver Dis 1993, 13:395-413.
19. Munoz S.J., Robinson M., Northrup B., et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology 1991, 13:209-212.
20. Wijdicks E.F., Plevak D.J., Rakela J., et al. Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 1995, 70:119-124.
21. Durham S., Yonas H., Aggarwal S., et al. Regional cerebral blood flow and CO2 reactivity in fulminant hepatic failure. J Cereb Blood Flow Metab 1995, 15:329-335.
22. Ardizzone G., Arrigo A., Panaro F., et al. Cerebral hemodynamic and metabolic changes in patients with fulminant hepatic failure during liver transplantation. Transplant Proc 2004, 36:3060-3064.
23. Aggarwal S., Obrist W., Yonas H., et al. Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome. Liver Transpl 2005, 11:1353-1360.
24. Bellner J., Romner B., Reinstrup P., et al. Transcranial Doppler sonography pulsatility index (PI) reflects intracranial pressure (ICP). Surg Neurol 2004, 62:45-51.
25. Aggarwal S., Brooks D.M., Kang Y., et al. Noninvasive monitoring of cerebral perfusion pressure in patients with acute liver failure using transcranial doppler ultrasonography. Liver Transpl 2008, 14:1048-1057.
26. Goetting M.G., Preston G. Jugular bulb catheterization: experience with 123 patients. Crit Care Med 1990, 18:1220-1223.
27. Raschke R.A., Curry S.C., Rempe S., et al. Results of a protocol for the management of patients with fulminant liver failure. Crit Care Med 2008, 36:2244-2248.
28. Blei A.T., Olafsson S., Webster S., et al. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993, 341:157-158.
29. Lisman T., Porte R.J. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010, 116:878-885.
30. Krisl J.C., Meadows H.E., Greenberg C.S., et al. Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures. Ann Pharmacother 2011, 45:1433-1438.
31. Le T.V., Rumbak M.J., Liu S.S., et al. Insertion of intracranial pressure monitors in fulminant hepatic failure patients: early experience using recombinant factor VII. Neurosurgery 2010, 66:455-458. [discussion 458].
32. Gasco J., Rangel-Castilla L., Franklin B., et al. State-of-the-art management and monitoring of brain edema and intracranial hypertension in fulminant hepatic failure. A proposed algorithm. Acta Neurochir Suppl 2010, 106:311-314.
33. Rabinstein A.A. Treatment of brain edema in acute liver failure. Curr Treat Options Neurol 2010, 12:129-141.
34. Bingaman W.E., Frank J.I. Malignant cerebral edema and intracranial hypertension. Neurol Clin 1995, 13:479-509.
35. Strauss G., Hansen B.A., Knudsen G.M., et al. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatology 1998, 28:199-203.
36. Ede R.J., Gimson A.E., Bihari D., et al. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatology 1986, 2:43-51.
37. Ede R., Gimson A.E., Cannalese J., et al. Cerebral oedema and monitoring of intracranial pressure in fulminant hepatic failure. Gastroenterol Jpn 1982, 17:163-176.
38. Tofteng F., Larsen F.S. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2004, 24:798-804.
39. Canalese J., Gimson A.E., Davis C., et al. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982, 23:625-629.
40. Jalan R. Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure. Neurochemistry Internat 2005, 47:78-83.
41. Murphy N., Auzinger G., Bernel W., et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004, 39:464-470.
42. Jalan R., Rose C. Hypothermia in acute liver failure. Metab Brain Dis 2004, 19:215-221.
43. Vaquero J., Blei A.T. Mild hypothermia for acute liver failure: a review of mechanisms of action. J Clin Gastroenterol 2005, 39:S147-S157.
44. Stravitz R.T., Larsen F.S. Therapeutic hypothermia for acute liver failure. Crit Care Med 2009, 37:S258-S264.
45. Jalan R., Damink O., Steven S.W., Deutz N.E., et al. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999, 354:1164-1168.
46. Jacob S., Khan A., Jacobs E.R., et al. Prolonged hypothermia as a bridge to recovery for cerebral edema and intracranial hypertension associated with fulminant hepatic failure. Neurocrit Care 2009, 11:242-246.
47. Wijdicks E.F., Nyberg S.L. Propofol to control intracranial pressure in fulminant hepatic failure. Transplantation Proc 2002, 34:1220-1222.
48. Bhatia V., Batra Y., Acharya S.K. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial. J Hepatology 2004, 41:89-96.
49. Montejo Gonzalez J.C., Catalan Gonzalez M., Meneu Diaz J.C., et al. Artificial liver support system in acute liver failure patients waiting liver transplantation. Hepatogastroenterology 2009, 56:456-461.
50. Huang Y.K., Tan D.M., Xie Y.T., et al. Randomized controlled study of plasma exchange combined with molecular adsorbent re-circulating system for the treatment of liver failure complicated with hepatic encephalopathy. Hepatogastroenterology 2012, 59:1323-1326.
51. Sen S., Rose C., Ytrebo L.M., et al. Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med 2006, 34:158-164.
52. Ryska M., Laszikova E., Pantoflicek T., et al. Fractionated plasma separation and adsorption significantly decreases intracranial pressure in acute liver failure: experimental study. Eur Surg Res 2009, 42:230-235.
53. Vaid A., Chweich H., Balk E.M., et al. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis. ASAIO J 2012, 58:51-59.
54. Camus C., Lavoue S., Gacouin A., et al. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy. Ther Apher Dial 2009, 13:549-555.
55. Bachli E.B., Schuepbach R.A., Maggiorini M., et al. Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. Liver Int 2007, 27:475-484.
56. Shinozaki K., Oda S., Abe R., et al. Blood purification in fulminant hepatic failure. Contrib Nephrol 2010, 166:64-72.